We next interrogated the endometrial carcinoma cohort of cases from the MSK-IMPACT study in order to determine whether CCND1 c-terminal mutations also occurred in the advanced or metastatic endometrial carcinoma setting [19]. The gene discussed is CCND1; the disease is endometrial carcinoma.